Navigation Links
ASP Sterrad Technology Approved by AFSSAPS for Total Inactivation of Prions

PARIS, April 27, 2010 /PRNewswire/ --

- French Health Products Safety Agency AFSSAPS Approves STERRAD(R) Hydrogen Peroxide Gas Plasma Technology for Total Inactivation of Protein-based Infectious Agents Linked to Fatal Brain Diseases

Advanced Sterilization Products (ASP) announced today that the French Health Products Safety Agency, AFSSAPS, will approve the low-temperature hydrogen peroxide gas plasma STERRAD(R) NX(TM) and the STERRAD(R) 100NX(TM) Sterilization Systems for total inactivation of prions.

Prions, which are protein-based infectious agents, cause neurodegenerative brain diseases characterized by the formation of "holes" in brain tissue. Prions are highly resistant to the commonly used procedures for inactivating them, and until recently, only the most severe sterilization processes had been proven effective.

"The effectiveness of low-temperature STERRAD(R) technology against the prion threat confirmed that is possible to eliminate these deadly pathogens while helping to preserve the integrity of medical devices, including heat sensitive surgical instruments," said Dr. Pascal Clayette, SPI-BIO, CEA, Fontenay-aux-Roses, France. "This is a great milestone for healthcare facilities who use an increasing number of sophisticated and costly surgical instruments and for patients who demand the most stringent infection prevention practices."

Following a number of in vivo and in vitro studies conducted on behalf of ASP by two independent laboratories in France and Germany, the STERRAD(R) NX(TM) Advanced Cycle and STERRAD(R) 100NX(TM) System Flex and Standard Cycles successfully provided prion inactivation and proved to be more effective on the prion threat than steam sterilization at 134degrees C for 18 minutes, which is the steam cycle recommended by the World Health Organization.

"The AFSSAPS approval of STERRAD(R) System sterilization technology for total inactivation of prions is another example of ASP's commitment to developing innovative infection prevention solutions that help raise the standards of care," said Chuck Austin, WW President of ASP. "STERRAD(R) Sterilization Systems are used by thousands of healthcare facilities across the globe and this new approval by the French Health Products Safety Agency is a significant benefit for customers and patients alike."

About STERRAD(R) Sterilization Systems

Engineered using ASP's breakthrough low-temperature gas plasma technology, STERRAD(R) Sterilization Systems terminally sterilize surgical instruments and medical devices safely and effectively, without the limitations or risks associated with peracetic acid, steam, formaldehyde and ethylene oxide gas systems. With thousands of units in use at hospitals and healthcare facilities around the world, STERRAD(R) Sterilization Systems produce a measurable return on hospital's sterilization investment by reducing instrument repair costs, offering rapid cycles, reducing instrument inventories and enhancing safety.

About Prion Diseases

Prion diseases, or proteinaceous infectious particle only agents, are able to induce abnormal folding of normal cellular prion proteins in the brain and can develop into neurodegenerative disorders including Gerstmann-Straussler-Scheinker Syndrome, fatal familial insomnia and Creutzfeldt-Jakob Disease (CJD) in humans. Such prion diseases can have long asymptomatic incubation periods but will result in fatality in all cases. Unlike infectious agents in other difficult-to-treat infectious diseases, prions exhibit an unusually high level of resistance to common sterilization methods and disinfection methods, including steam, and pose a threat to infection prevention in healthcare facilities.

About the Data

ASP, through the use of several independent laboratories in France and Germany produced a set of comprehensive studies on prion inactivation. 61 tests (41 in vivo and over 20 in vitro controls) evaluating and comparing disinfection, washing and sterilization procedures were performed. In these studies, the STERRAD(R) NX(TM) Advanced Cycle and STERRAD(R) 100NX(TM) System Flex and Standard Cycles proved to be more effective in prion inactivation than a steam cycle at 134degreesC, 18 minutes- a special optimized steam cycle recommended by the World Health Organization against prions.

About Advanced Sterilization Products (ASP)

Advanced Sterilization Products (ASP), a Division of Ethicon, Inc., a Johnson & Johnson company is a leading developer of innovative instrument sterilization, high level disinfection and cleaning technologies. The company is dedicated to protecting patients, healthcare workers, and the environment with products that focus as much on safety as they do on efficacy and cost-effectiveness. Utilizing advanced instrument processing technologies, these products help customers to promote positive patient outcomes while controlling costs, increasing productivity and enhancing safety. The company is based in Irvine, California with offices around the world.

    ASP - UK Johnson & Johnson Media Relations
    Komel Bajwe
    APCO Worldwide

SOURCE Advanced Sterilization Products
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. Novel Technology Breaks Through Cancer Pain
3. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
4. Advanced Cell Technology Announces Proposed Financing
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
10. China Technology Announces New Chief Financial Officer
11. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
Post Your Comments:
(Date:10/8/2015)... SAN DIEGO , Oct. 8, 2015 /PRNewswire/ ... oncology company developing new treatments for cancer and ... Chief Executive Officer, will be presenting at the ... Las Vegas :Event:Aegis Capital Corporation 2015 ... PDTLocation:Brahms 2 room, The Encore @ The Wynn ...
(Date:10/8/2015)... , Oct. 8, 2015  ATCC, the premier ... that it has been selected by The Michael J. ... cell lines to academic, pharmaceutical, and biotechnology organizations committed ... the United States , and more ... the United States , and more ...
(Date:10/8/2015)... , Oct. 8, 2015 Celemics, a global ... into the North American market with the establishment of ... and Europe , has secured ... Target Enrichment methodology and sample preparation for DNA sequencing ... both hereditary and somatic genetic testing more accurately, quickly, ...
(Date:10/8/2015)... October 8, 2015 Global ... Global Biologics and Biosimilars industry . --> ... Biologics and Biosimilars Industry 2015 Deep Market Research ... is a professional and depth research report on ... ) , --> ...
Breaking Biology Technology:
... RICHMOND, Va., June 20 Insmed Inc. (Nasdaq:,INSM), ... that it intends to request a hearing before ... an earlier Staff Determination,to delist the Company,s common ... received a letter from The NASDAQ Stock Market ...
... Initiated to Find Suitable Candidate, WESLEY CHAPEL, ... today that Eran Rotem, its Chief,Financial Officer, who ... June 2008. The Company has initiated search for ... this position., Ram Ajjarapu commented: "We appreciate ...
... Germany – June 20, 2008 / b3c newswire ... contract manufacturing organization (CMO) for the development and ... of a 2,500 L multi-process production suite. Hence, ... with volumes of 30, 250, 500 and 2,500 ...
Cached Biology Technology:
(Date:9/30/2015)... Sept. 30, 2015  With nearly 300,000 Americans living ... new SCIs estimated to reach 12,500 annually, the role ... Resource Services for Independent Living (SCRS-IL) is increasingly ... California opening doors to independence for ... and services, notably assistive technology services and education. ...
(Date:9/29/2015)... SUNNYVALE, Calif. , Sept. 29, 2015 ... technology improves employee productivity while also saving energy ... features such as Low Power Active Mode and embedded ... workplace transformation Fujitsu today shows that ... of new and refreshed models to its enterprise desktop ...
(Date:9/28/2015)... Sept. 28, 2015  The monitoring of vital ... body temperature, is an essential component of patient ... of deterioration in a patient,s condition. However, in ... are typically taken during routine observation rounds only ... patient deteriorates between these observation rounds, the warning ...
Breaking Biology News(10 mins):
... Comparative Biology (SICB), one of the oldest and most ... at the Hilton San Francisco, Union Square, in San ... than 1,500 scientists will present the latest research on ... a rich assortment of news and feature possibilities. ...
... in biology are given the freedom to play, dabble in ... worry about getting "good" results? In the case ... level of new knowledge and publications generated by student-and-faculty teams. ... magazine, several scientists who have directed the Physiology course detail ...
... Chinese research team, led by Beijing Forestry University, BGI, Beijing ... has completed the first genomic sequence of Prunus mume ... the deeper understanding of Rosaceae evolution and provides an invaluable ... was published online today in Nature Communication ., As ...
Cached Biology News:
Request Info...
Recombinant Equine TNF-alpha/TNFSF1A, CF...
Recombinant Equine IL-4, CF...
actin from rabbit muscle Cell Biology Cytoskeletal Probes Actin and Actin Probes...
Biology Products: